Petroleo Brasileiro Petrobras SA ADR (PBR)vsSanofi ADR (SNY)
PBR
Petroleo Brasileiro Petrobras SA ADR
$19.82
+0.35%
ENERGY · Cap: $84.28B
SNY
Sanofi ADR
$46.03
+1.97%
HEALTHCARE · Cap: $109.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Petroleo Brasileiro Petrobras SA ADR generates 952% more annual revenue ($491.45B vs $46.72B). SNY leads profitability with a 16.7% profit margin vs 15.8%. PBR appears more attractively valued with a PEG of 0.33. PBR earns a higher WallStSmart Score of 69/100 (B-).
PBR
Strong Buy69
out of 100
Grade: B-
SNY
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+3.6%
Fair Value
$16.42
Current Price
$19.82
$3.40 discount
Margin of Safety
-89.7%
Fair Value
$24.79
Current Price
$46.03
$21.24 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 36.2%
Large-cap with strong market position
Generating 2.8B in free cash flow
Reasonable price relative to book value
Large-cap with strong market position
Generating 1.6B in free cash flow
Areas to Watch
0.5% earnings growth
Revenue declined 1.3%
Distress zone — elevated risk
2.4% earnings growth
ROE of 6.7% — below average capital efficiency
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : PBR
The strongest argument for PBR centers on PEG Ratio, P/E Ratio, Price/Book. Profitability is solid with margins at 15.8% and operating margin at 36.2%. PEG of 0.33 suggests the stock is reasonably priced for its growth.
Bull Case : SNY
The strongest argument for SNY centers on Price/Book, Market Cap, Free Cash Flow. Profitability is solid with margins at 16.7% and operating margin at 14.3%.
Bear Case : PBR
The primary concerns for PBR are EPS Growth, Revenue Growth, Altman Z-Score.
Bear Case : SNY
The primary concerns for SNY are EPS Growth, Return on Equity, PEG Ratio.
Key Dynamics to Monitor
PBR profiles as a declining stock while SNY is a mature play — different risk/reward profiles.
SNY carries more volatility with a beta of 0.36 — expect wider price swings.
SNY is growing revenue faster at 6.9% — sustainability is the question.
PBR generates stronger free cash flow (2.8B), providing more financial flexibility.
Bottom Line
PBR scores higher overall (69/100 vs 49/100), backed by strong 15.8% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Petroleo Brasileiro Petrobras SA ADR
ENERGY · OIL & GAS INTEGRATED · USA
Petrleo Brasileiro SA - Petrobras produces and sells oil and gas in Brazil and internationally. The company is headquartered in Rio de Janeiro, Brazil.
Visit Website →Sanofi ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Compare with Other OIL & GAS INTEGRATED Stocks
Want to dig deeper into these stocks?